70.10.Z - Activities of head office and holding companies, excluding financial holding companies
46.18.Z - Agents specialised in the sale of other particular products
46.46.Z - Wholesale of pharmaceutical goods
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
64.20.Z - Activities of holding companies
72.19.Z - Other research and experimental development on natural sciences and engineering
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
86.90.D - Paramedical activities
86.90.E - Other human health activities notelsewhere classified
96.09.Z - Other personal service activities not elsewhere classified
2019 | 2020 | 2021 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 1855,6 | |||
Gross profit (loss) | 0,1 | 0 | -0 | -112,3 |
EBITDA | 0 | -0 | -112,1 | |
Short time liabilities | 0,2 | 0,2 | 0,2 | 2,9 |
Other operating costs | -∞ | |||
Equity capital | 2 | 2 | 2 | -0,2 |
Operating profit (EBIT) | 0,1 | 0 | -0 | -112,1 |
Assets | 2,1 | 2,2 | 2,2 | 0 |
Net profit (loss) | 0,1 | 0 | -0 | -113,7 |
Cash | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 0,2 | 0,2 | 0,2 | 2,9 |
Net income from sale | 0,2 | 0,1 | 0 | -100 |
Working assets | 0,2 | 0,2 | 0,2 | 0,5 |
Other income costs | -∞ | |||
Depreciation | 0 | 0 | 0 | |
% | % | % | p.p. | |
Profitability of capital | 6,6 | 1,7 | -0,2 | -1,9 |
Equity capital to total assets | 91,9 | 91,6 | 91,4 | -0,2 |
Gross profit margin | 60,8 | 26,9 | -33,9 | |
EBITDA Margin | 27,3 | -51,3 | ||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 268 | 485 | 2 147 483 648 | 2 147 483 163 |
Current financial liquidity indicator | 1.1564481258392334 | 1.1296555995941162 | -0,1 | |
Net dept to EBITDA | -0.2812025547027588 | 2.3253002166748047 | 2,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane